Background and Aims
Celiac disease (CD) is a chronic immune-mediated enteropathy that is precipitated by dietary gluten in genetically predisposed individuals. A few studies reported a higher incidence of pancreatitis in the CD population. Using a large US database, we sought to describe the epidemiology, risk, and outcomes of acute pancreatitis (AP) and chronic pancreatitis (CP) in CD patients.
We queried a multiple health system data analytics and research platform (Explorys Inc, Cleveland, OH, USA). A cohort of patients with a diagnosis of CD was identified. Subsequently, individuals who developed a new diagnosis of AP and CP after at least 30 days of being diagnosed with CD were identified. A multivariate regression model was performed to adjust for multiple confounding factors.
Of the 72,965,940 individuals in the database, 133,400 (0.18%), 362,050 (0.50%), and 95,190 (0.13%) had CD, AP, and CP, respectively. New diagnosis of AP and CP after at least 30 days of CD diagnosis was 1.06%, 0.52%, respectively, compared to non-CD patients with 0.49% for AP and 0.13% for CP, P < .0001. In multivariate regression analysis, patients with CD were at higher risk of developing AP [OR 2.66; 95% CI 2.55–2.77] and CP [OR 2.18; 95% CI 2.04–2.34]. Idiopathic AP was the most common etiology among CD patients [OR 1.54; 95% CI 1.34–1.77].
In this largest US population database and after adjusting for several confounders, patients with CD were at increased risk of developing AP and CP. Celiac disease patients had worse outcomes and higher medical burden compared to non-CD patients. Recurrent abdominal pain that suggests pancreatic etiology, idiopathic pancreatitis, or elevation of pancreatic enzymes should warrant investigation for CD as a potential cause of pancreatic disease.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Acute respiratory distress syndrome
Health Insurance Portability and Accountability Act
International Classification of Diseases
Institutional Review Board
Systematized Nomenclature of Medicine-Clinical Terms
Tye-Din JA, Galipeau HJ, Agardh D. Celiac disease: a review of current concepts in pathogenesis, prevention, and novel therapies. Front Pediatr. 2018;6:350. https://doi.org/10.3389/fped.2018.00350.
McAllister BP, Williams E, Clarke K. A comprehensive review of celiac disease/gluten-sensitive enteropathies. Clin Rev Allergy Immunol. 2019;57:226–243. https://doi.org/10.1007/s12016-018-8691-2.
Kim H, Patel KG, Orosz E, et al. Time trends in the prevalence of celiac disease and gluten-free diet in the US population: results from the National Health and Nutrition Examination Surveys 2009–2014. JAMA Intern Med. 2016;176:1716–1717. https://doi.org/10.1001/jamainternmed.2016.5254.
Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107(10):1538–1544. https://doi.org/10.1038/ajg.2012.219. (quiz 7, 45).
Kelly CP, Bai JC, Liu E, Leffler DA. Advances in diagnosis and management of celiac disease. Gastroenterology. 2015;148:1175–1186. https://doi.org/10.1053/j.gastro.2015.01.044.
Bultron G, Latif U, Park A, Phatak U, Pashankar D, Husain SZ. Acute pancreatitis in a child with celiac disease. J Pediatr Gastroenterol Nutr. 2009;49:137–138. https://doi.org/10.1097/mpg.0b013e318172aad1.
Basha J, Appasani S, Vaiphei K, Singh K, Kochhar R. Celiac disease presenting as recurrent pancreatitis and pseudocyst. JOP. 2012;13:533–535.
Halabi IM. Coeliac disease presenting as acute pancreatitis in a 3-year-old. Ann Trop Paediatr. 2010;30:255–257. https://doi.org/10.1179/146532810x12786388978887.
Maher Shahrour MS, Haleem RA, Ciecierega T. Celiac disease presenting as acute pancreatitis: a case report and review of the literature. J Gastrointest Dig Syst. 2015;. https://doi.org/10.4172/2161-069x.1000344.
Rana SS, Bhasin DK, Sinha SK, Singh K. Coexistence of chronic calcific pancreatitis and celiac disease. Indian J Gastroenterol. 2007;26(3):150. (author reply).
Sood A, Midha V, Sood N, et al. Coexistence of chronic calcific pancreatitis and celiac disease. Indian J Gastroenterol. 2007;26:41–42.
Fitzgerald O, Fitzgerald P, Fennelly J, McMullin JP, Boland SJ. A clinical study of chronic pancreatitis. Gut. 1963;4:193–216. https://doi.org/10.1136/gut.4.3.193.
Pitchumoni CS, Thomas E, Balthazar E, Sherling B. Chronic calcific pancreatitis in association with celiac disease. Am J Gastroenterol. 1977;68:358–361.
Regan PT, DiMagno EP. Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure. Gastroenterology. 1980;78:484–487.
Patel RS, Johlin FC Jr, Murray JA. Celiac disease and recurrent pancreatitis. Gastrointest Endosc. 1999;50:823–827. https://doi.org/10.1016/s0016-5107(99)70166-5.
Ludvigsson JF, Montgomery SM, Ekbom A. Risk of pancreatitis in 14,000 individuals with celiac disease. Clin Gastroenterol Hepatol. 2007;5:1347–1353. https://doi.org/10.1016/j.cgh.2007.06.002.
Sadr-Azodi O, Sanders DS, Murray JA, Ludvigsson JF. Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol. 2012;10(10):1136–1142. https://doi.org/10.1016/j.cgh.2012.06.023.
IBM Corporation. The IBM Explorys Platform: liberate your healthcare data. https://www.ibm.com/downloads/cas/4P0QB9JN. Last accessed January 28, 2020.
US National Library of Medicine Unified Medical Language System (UMLS). Systematized Nomenclature of Medicine–Clinical Terms (SNOMED CT). https://www.nlm.nih.gov/research/umls/Snomed/snomed_main.html. Accessed January 28, 2020.
Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc. 2011;18:441–448. https://doi.org/10.1136/amiajnl-2011-000116.
Team, E. We unlock the power of BIG DATA to improve healthcare for everyone. Explorys. 2015. 2016.
Mansoor E, Saleh MA, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, From 2012 to 2017. Clin Gastroenterol Hepatol. 2017;15:1733–1741. https://doi.org/10.1016/j.cgh.2017.05.050.
Abou Saleh M, Mansoor E, Anindo M, Isenberg G. Prevalence of small intestine carcinoid tumors: a US population-based study 2012–2017. Dig Dis Sci. 2019;64:1328–1334. https://doi.org/10.1007/s10620-018-5402-z.
Tandon BN, George PK, Sama SK, Ramachandran K, Gandhi PC. Exocrine pancreatic function in protein-calorie malnutrition disease of adults. Am J Clin Nutr. 1969;22:1476–1482. https://doi.org/10.1093/ajcn/22.11.1476.
Brooks SE, Golden MH. The exocrine pancreas in kwashiorkor and marasmus. Light and electron microscopy. West Indian Med J. 1992;41(2):56–60.
Pitchumoni CS. Pancreas in primary malnutrition disorders. Am J Clin Nutr. 1973;26:374–379. https://doi.org/10.1093/ajcn/26.3.374.
Davies JNP. The essential pathology of Kwashiorkor. Lancet. 1948;1(6496):317–320.
Maton PN, Selden AC, Fitzpatrick ML, Chadwick VS. Defective gallbladder emptying and cholecystokinin release in celiac disease. Reversal by gluten-free diet. Gastroenterology. 1985;88:391–396. https://doi.org/10.1016/0016-5085(85)90497-4.
Kilander AF, Hanssen LE, Gillberg RE. Secretin release in coeliac disease. Plasma secretin concentration and bicarbonate output to the duodenum after intraduodenal acid infusion in coeliac patients before and after treatment. Scand J Gastroenterol. 1983;18:765–769. https://doi.org/10.3109/00365528309182092.
Carroccio A, Di Prima L, Scalici C, et al. Unexplained elevated serum pancreatic enzymes: a reason to suspect celiac disease. Clin Gastroenterol Hepatol. 2006;4:455–459. https://doi.org/10.1016/j.cgh.2005.12.027.
Freeman HJ. Celiac-associated pancreatic disease. Ann Gastroenterol. 2016;29:241–242. https://doi.org/10.20524/aog.2016.0048.
Rabsztyn A, Green PH, Berti I, Fasano A, Perman JA, Horvath K. Macroamylasemia in patients with celiac disease. Am J Gastroenterol. 2001;96:1096–1100. https://doi.org/10.1111/j.1572-0241.2001.03746.x.
Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003;163:1566–1572. https://doi.org/10.1001/archinte.163.13.1566.
Ivarsson A, Persson L, Juto P, Peltonen M, Suhr O, Hernell O. High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med. 1999;245:63–68.
Askling J, Linet M, Gridley G, Halstensen TS, Ekström K, Ekbom AJG. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428–1435.
Cavell B, Stenhammar L, Ascher H, et al. Increasing incidence of childhood coeliac disease in Sweden. Results of a national study. Acta Paediatr. 1992;81:589–592.
Choung RS, Ditah IC, Nadeau AM, et al. Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol. 2015;110:455–461. https://doi.org/10.1038/ajg.2015.8.
Mardini HE, Westgate P, Grigorian AY. Racial differences in the prevalence of celiac disease in the US population: National Health and Nutrition Examination Survey (NHANES) 2009–2012. Dig Dis Sci. 2015;60:1738–1742. https://doi.org/10.1007/s10620-014-3514-7.
Singh VK, Haupt ME, Geller DE, Hall JA, Quintana Diez PM. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol. 2017;23:7059–7076. https://doi.org/10.3748/wjg.v23.i39.7059.
Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol. 2002;97:2016–2021. https://doi.org/10.1111/j.1572-0241.2002.05917.x.
Nousia-Arvanitakis S, Karagiozoglou-Lamboudes T, Aggouridaki C, Malaka-Lambrellis E, Galli-Tsinopoulou A, Xefteri M. Influence of jejunal morphology changes on exocrine pancreatic function in celiac disease. J Pediatr Gastroenterol Nutr. 1999;29:81–85. https://doi.org/10.1097/00005176-199907000-00019.
Nousia-Arvanitakis S, Fotoulaki M, Tendzidou K, Vassilaki C, Agguridaki C, Karamouzis M. Subclinical exocrine pancreatic dysfunction resulting from decreased cholecystokinin secretion in the presence of intestinal villous atrophy. J Pediatr Gastroenterol Nutr. 2006;43:307–312. https://doi.org/10.1097/01.mpg.0000228098.66583.85.
Carroccio A, Iacono G, Montalto G, et al. Exocrine pancreatic function in children with coeliac disease before and after a gluten free diet. Gut. 1991;32:796–799. https://doi.org/10.1136/gut.32.7.796.
Pfefferle KJ, Gil KM, Fening SD, Dilisio MF. Validation study of a pooled electronic healthcare database: the effect of obesity on the revision rate of total knee arthroplasty. Eur J Orthop Surg Traumatol. 2014;24:1625–1628. https://doi.org/10.1007/s00590-014-1423-2.
Iyengar A, Kundu A, Sharma U, Zhang P. A trusted healthcare data analytics cloud platform. In 2018 IEEE 38th International Conference on Distributed Computing Systems (ICDCS). 2018:1238–1249.
Nadkarni PM, Darer JA. Migrating existing clinical content from ICD-9 to SNOMED. J Am Med Inform Assoc JAMIA. 2010;17:602–607. https://doi.org/10.1136/jamia.2009.001057.
A Karb D, A Mansoor E, A Parasa S, A Cooper GS. T Prevalence of diagnosed celiac disease and associated conditions in the United States between 2012–2017: results from a National Electronic Patient Database 2019.
Conflict of interest
There are no potential conflicts (financial, professional, or personal) to disclose by all the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Alkhayyat, M., Saleh, M.A., Abureesh, M. et al. The Risk of Acute and Chronic Pancreatitis in Celiac Disease. Dig Dis Sci 66, 2691–2699 (2021). https://doi.org/10.1007/s10620-020-06546-2
- Risk factors
- Celiac disease